In pancreatic cancer, patients with low SIRT3 expression seem to exhibit a rapid recurrence and short survival, while high SIRT3 expression could inhibit in vitro cell proliferation (20, 21, 22). This evidence concerns the gene SIRT3 and familial pancreatic carcinoma.